CEPI to develop vaccine printing technology with biotech firm


In a move to defeat the next pandemic, the CEPI (Coalition for Epidemic Preparedness Innovations) has reportedly signed an agreement with CureVac, a German biopharmaceutical firm. The duo plan to develop a vaccine printing technology, with an aim to produce shots against various diseases.

Content Information

Content Author: 
Akshay Kedari
Content Source: 
Healthcare Opportunity
Content Type: 
News